NEW YORK (GenomeWeb) – Pressure BioSciences today reported that its third quarter revenues jumped 56 percent year over year, driven by increases in sales from products and services.

The South Easton, Massachusetts-based sample prep technologies firm reported total revenues of $580,334 for the three months ended Sept. 30 compared to $372,545 for the third quarter of 2014. Its products, services, and other sales jumped to $481,452 from $372,545 year over year, while the firm also reported $98,882 in grant revenue for the quarter compared to no such revenue in last year's Q3.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.